Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

235 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies.
Michelson D, Adler L, Spencer T, Reimherr FW, West SA, Allen AJ, Kelsey D, Wernicke J, Dietrich A, Milton D. Michelson D, et al. Among authors: allen aj. Biol Psychiatry. 2003 Jan 15;53(2):112-20. doi: 10.1016/s0006-3223(02)01671-2. Biol Psychiatry. 2003. PMID: 12547466 Clinical Trial.
Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders.
Allen AJ, Kurlan RM, Gilbert DL, Coffey BJ, Linder SL, Lewis DW, Winner PK, Dunn DW, Dure LS, Sallee FR, Milton DR, Mintz MI, Ricardi RK, Erenberg G, Layton LL, Feldman PD, Kelsey DK, Spencer TJ. Allen AJ, et al. Neurology. 2005 Dec 27;65(12):1941-9. doi: 10.1212/01.wnl.0000188869.58300.a7. Neurology. 2005. PMID: 16380617 Clinical Trial.
Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study.
Michelson D, Allen AJ, Busner J, Casat C, Dunn D, Kratochvil C, Newcorn J, Sallee FR, Sangal RB, Saylor K, West S, Kelsey D, Wernicke J, Trapp NJ, Harder D. Michelson D, et al. Among authors: allen aj. Am J Psychiatry. 2002 Nov;159(11):1896-901. doi: 10.1176/appi.ajp.159.11.1896. Am J Psychiatry. 2002. PMID: 12411225 Clinical Trial.
Changes in symptoms and adverse events after discontinuation of atomoxetine in children and adults with attention deficit/hyperactivity disorder: a prospective, placebo-controlled assessment.
Wernicke JF, Adler L, Spencer T, West SA, Allen AJ, Heiligenstein J, Milton D, Ruff D, Brown WJ, Kelsey D, Michelson D. Wernicke JF, et al. Among authors: allen aj. J Clin Psychopharmacol. 2004 Feb;24(1):30-5. doi: 10.1097/01.jcp.0000104907.75206.c2. J Clin Psychopharmacol. 2004. PMID: 14709944 Clinical Trial.
High-dose atomoxetine treatment of ADHD in youths with limited response to standard doses.
Kratochvil CJ, Michelson D, Newcorn JH, Weiss MD, Busner J, Moore RJ, Ruff DD, Ramsey J, Dickson R, Turgay A, Saylor KE, Luber S, Vaughan B, Allen AJ; ATOMOXETINE HIGH-DOSE STUDY GROUP. Kratochvil CJ, et al. Among authors: allen aj. J Am Acad Child Adolesc Psychiatry. 2007 Sep;46(9):1128-1137. doi: 10.1097/chi.0b013e318074eeb3. J Am Acad Child Adolesc Psychiatry. 2007. PMID: 17712236 Clinical Trial.
Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial.
Kelsey DK, Sumner CR, Casat CD, Coury DL, Quintana H, Saylor KE, Sutton VK, Gonzales J, Malcolm SK, Schuh KJ, Allen AJ. Kelsey DK, et al. Among authors: allen aj. Pediatrics. 2004 Jul;114(1):e1-8. doi: 10.1542/peds.114.1.e1. Pediatrics. 2004. PMID: 15231966 Clinical Trial.
235 results